David Gascoigne

Dallas’ Almaden Genomics Launches New Data Management and Informatics Service Business

by | Sep 18, 2024
Almaden—which was formerly part of IBM Research before launching as a standalone company in 2022 under Catalyze Dallas ownership—aims to complement its g.nome workflow platform with the new service business. The goal: providing solutions that streamline data analysis and management in drug discovery, diagnostics, biotech research, and more.
MORE
Three Months After Launching With Its g.nome Platform, Almaden Genomics Names CEO
by | Jan 30, 2023
Life sciences industry veteran David Gascoigne will lead the new startup, which was launched in October by Catalyze Dallas Holdings. Almaden's g.nome cloud-native platform offers "an advanced visual drag-and-drop workflow builder" and curated library of toolkits that can speed bioinformatic pipeline building "from what previously has taken months to mere hours," the company says.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.